NuCana PLC (NCNA)
1.24
-0.03
(-2.36%)
USD |
NASDAQ |
Nov 22, 11:39
NuCana Total Liabilities (Quarterly): 20.58M for June 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 20.58M |
| March 31, 2024 | 18.52M |
| December 31, 2023 | 16.46M |
| September 30, 2023 | 14.88M |
| June 30, 2023 | 17.50M |
| March 31, 2023 | 21.05M |
| December 31, 2022 | 23.90M |
| September 30, 2022 | 17.83M |
| June 30, 2022 | 12.85M |
| March 31, 2022 | 16.69M |
| December 31, 2021 | 16.10M |
| September 30, 2021 | 16.57M |
| June 30, 2021 | 11.25M |
| March 31, 2021 | 12.93M |
| December 31, 2020 | 11.67M |
| Date | Value |
|---|---|
| September 30, 2020 | 12.36M |
| June 30, 2020 | 8.580M |
| March 31, 2020 | 8.117M |
| December 31, 2019 | 8.845M |
| September 30, 2019 | 7.051M |
| June 30, 2019 | 8.833M |
| March 31, 2019 | 7.273M |
| December 31, 2018 | 7.094M |
| September 30, 2018 | 6.814M |
| June 30, 2018 | 5.450M |
| March 31, 2018 | 3.535M |
| December 31, 2017 | 3.966M |
| June 30, 2017 | 2.935M |
| December 31, 2016 | 2.424M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
8.117M
Minimum
Mar 2020
23.90M
Maximum
Dec 2022
15.09M
Average
16.10M
Median
Dec 2021
Total Liabilities (Quarterly) Benchmarks
| Adaptimmune Therapeutics PLC | 237.45M |
| Biodexa Pharmaceuticals PLC | 6.628M |
| Autolus Therapeutics PLC | 350.52M |
| Mereo BioPharma Group PLC | 16.21M |
| Bicycle Therapeutics PLC | 165.71M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 25.38M |
| Shareholders Equity (Quarterly) | 4.806M |